Banco Products (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 23, 2025, 1:47 am

Market Cap	7,942 Cr.
Current Price	556
High / Low	603/259
Stock P/E	20.3
Book Value	91.1
Dividend Yield	1.98 %
ROCE	33.4 %
ROE	33.3 %
Face Value	2.00
PEG Ratio	0.93

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Banco Products (India) Ltd

Competitors of Banco Products (India) Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
IP Rings Ltd	199 Cr.	157	262/108		82.8	0.00 %	4.05 %	2.95 %	10.0
Talbros Automotive Components Ltd	1,769 Cr.	286	396/200	20.1	96.4	0.24 %	21.4 %	17.2 %	2.00
Sundram Fasteners Ltd	20,966 Cr.	998	1,506/831	38.9	181	0.72 %	17.1 %	14.9 %	1.00
Sintercom India Ltd	363 Cr.	132	186/110	542	36.9	0.00 %	4.52 %	0.66 %	10.0
Shriram Pistons & Rings Ltd	10,786 Cr.	2,447	2,570/1,556	21.3	543	0.41 %	26.0 %	23.5 %	10.0
Industry Average	11,649.58 Cr	3,124.87		76.32	505.95	0.74%	16.45%	14.45%	7.25

All Competitor Stocks of Banco Products (India) Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	402	507	586	628	509	609	749	725	571	724	804	895	639
Expenses	363	427	519	569	369	511	653	602	482	610	671	689	581
Operating Profit	40	80	67	59	140	98	97	122	89	114	133	206	58
OPM %	10%	16%	11%	9%	28%	16%	13%	17%	16%	16%	17%	23%	9%
Other Income	-3	-1	1	10	1	3	16	3	12	6	2	17	5
Interest	1	3	2	1	3	7	5	6	4	7	7	6	5
Depreciation	8	24	12	12	13	20	15	16	17	28	19	19	20
Profit before tax	28	53	55	56	126	74	93	104	81	86	109	197	39
Tax %	40%	23%	37%	8%	22%	31%	26%	36%	15%	20%	37%	30%	21%
Net Profit	17	40	35	52	98	51	69	66	68	68	69	139	31
EPS in Rs	1.20	2.81	2.42	3.62	6.87	3.57	4.81	4.62	4.78	4.77	4.80	9.70	2.16

Last Updated: March 3, 2025, 5:21 pm

Below is a detailed analysis of the quarterly data for Banco Products (India) Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 639.00 Cr.. The value appears to be declining and may need further review. It has decreased from 895.00 Cr. (Sep 2024) to 639.00 Cr., marking a decrease of 256.00 Cr..
For Expenses, as of Dec 2024, the value is 581.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 689.00 Cr. (Sep 2024) to 581.00 Cr., marking a decrease of 108.00 Cr..
For Operating Profit, as of Dec 2024, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Sep 2024) to 58.00 Cr., marking a decrease of 148.00 Cr..
For OPM %, as of Dec 2024, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Sep 2024) to 9.00%, marking a decrease of 14.00%.
For Other Income, as of Dec 2024, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Sep 2024) to 5.00 Cr., marking a decrease of 12.00 Cr..
For Interest, as of Dec 2024, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Sep 2024) to 5.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Sep 2024) to 20.00 Cr., marking an increase of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 197.00 Cr. (Sep 2024) to 39.00 Cr., marking a decrease of 158.00 Cr..
For Tax %, as of Dec 2024, the value is 21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Sep 2024) to 21.00%, marking a decrease of 9.00%.
For Net Profit, as of Dec 2024, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 139.00 Cr. (Sep 2024) to 31.00 Cr., marking a decrease of 108.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 2.16. The value appears to be declining and may need further review. It has decreased from 9.70 (Sep 2024) to 2.16, marking a decrease of 7.54.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:07 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,024	1,116	1,129	1,148	1,239	1,336	1,567	1,422	1,533	1,958	2,332	2,768	3,062
Expenses	905	951	1,027	1,002	1,096	1,157	1,405	1,300	1,354	1,686	1,966	2,340	2,551
Operating Profit	119	165	102	146	144	179	161	122	178	272	366	428	511
OPM %	12%	15%	9%	13%	12%	13%	10%	9%	12%	14%	16%	15%	17%
Other Income	9	9	53	11	32	18	10	25	9	5	14	32	31
Interest	16	19	8	3	2	2	4	3	4	5	13	21	24
Depreciation	29	32	34	35	33	28	29	33	34	48	56	76	87
Profit before tax	83	122	113	119	141	167	138	111	150	224	311	363	430
Tax %	26%	26%	22%	25%	31%	30%	50%	31%	24%	32%	24%	25%
Net Profit	61	90	88	90	97	117	69	77	114	152	236	271	306
EPS in Rs	4.29	6.28	6.13	6.29	6.80	8.17	4.83	5.36	7.95	10.66	16.47	18.98	21.43
Dividend Payout %	21%	16%	24%	37%	66%	61%	83%	187%	13%	94%	67%	53%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	47.54%	-2.22%	2.27%	7.78%	20.62%	-41.03%	11.59%	48.05%	33.33%	55.26%	14.83%
Change in YoY Net Profit Growth (%)	0.00%	-49.76%	4.49%	5.51%	12.84%	-61.64%	52.62%	36.46%	-14.72%	21.93%	-40.43%

Banco Products (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	11%
5 Years:	18%
3 Years:	18%
TTM:	16%

Compounded Profit Growth
10 Years:	21%
5 Years:	40%
3 Years:	37%
TTM:	42%

Stock Price CAGR
10 Years:	27%
5 Years:	79%
3 Years:	106%
1 Year:	75%

Return on Equity
10 Years:	19%
5 Years:	24%
3 Years:	28%
Last Year:	33%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:37 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	14	14	14	14	14	14	14	14	14	14	14	14	14
Reserves	458	574	605	674	705	793	818	696	814	967	987	1,037	1,259
Borrowings	214	172	36	36	38	34	40	92	14	115	418	423	420
Other Liabilities	168	183	164	232	211	356	322	287	344	405	435	508	648
Total Liabilities	854	944	819	956	969	1,197	1,195	1,089	1,187	1,502	1,855	1,982	2,342
Fixed Assets	232	243	227	221	192	191	184	193	190	297	359	454	447
CWIP	9	12	11	3	4	13	13	3	1	15	18	10	12
Investments	62	71	1	1	91	24	69	9	1	1	0	0	31
Other Assets	551	618	581	731	682	969	929	883	995	1,190	1,477	1,518	1,852
Total Assets	854	944	819	956	969	1,197	1,195	1,089	1,187	1,502	1,855	1,982	2,342

Below is a detailed analysis of the balance sheet data for Banco Products (India) Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
For Reserves, as of Sep 2024, the value is 1,259.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,037.00 Cr. (Mar 2024) to 1,259.00 Cr., marking an increase of 222.00 Cr..
For Borrowings, as of Sep 2024, the value is 420.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 423.00 Cr. (Mar 2024) to 420.00 Cr., marking a decrease of 3.00 Cr..
For Other Liabilities, as of Sep 2024, the value is 648.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 508.00 Cr. (Mar 2024) to 648.00 Cr., marking an increase of 140.00 Cr..
For Total Liabilities, as of Sep 2024, the value is 2,342.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,982.00 Cr. (Mar 2024) to 2,342.00 Cr., marking an increase of 360.00 Cr..
For Fixed Assets, as of Sep 2024, the value is 447.00 Cr.. The value appears to be declining and may need further review. It has decreased from 454.00 Cr. (Mar 2024) to 447.00 Cr., marking a decrease of 7.00 Cr..
For CWIP, as of Sep 2024, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 2.00 Cr..
For Investments, as of Sep 2024, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 31.00 Cr., marking an increase of 31.00 Cr..
For Other Assets, as of Sep 2024, the value is 1,852.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,518.00 Cr. (Mar 2024) to 1,852.00 Cr., marking an increase of 334.00 Cr..
For Total Assets, as of Sep 2024, the value is 2,342.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,982.00 Cr. (Mar 2024) to 2,342.00 Cr., marking an increase of 360.00 Cr..

Notably, the Reserves (1,259.00 Cr.) exceed the Borrowings (420.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	131	85	68	90	99	62	52	157	57	-41	458	164
Cash from Investing Activity +	-42	88	-17	-59	-22	-52	149	-59	-104	-23	-114	-73
Cash from Financing Activity +	-82	-136	-6	-61	-68	-49	-153	-78	-11	59	-339	-89
Net Cash Flow	7	36	46	-30	9	-39	49	20	-58	-6	5	3

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-95.00	-7.00	66.00	110.00	106.00	145.00	121.00	30.00	164.00	157.00	-52.00	5.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	69	70	57	70	60	70	63	75	64	60	65	63
Inventory Days	178	172	152	190	171	217	191	212	234	225	271	210
Days Payable	53	57	39	71	51	90	102	99	118	95	95	90
Cash Conversion Cycle	194	184	170	189	180	197	152	188	180	191	241	183
Working Capital Days	102	107	106	118	116	116	119	142	134	139	166	131
ROCE %	15%	19%	12%	18%	17%	21%	17%	13%	19%	24%	26%	27%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	67.88%	67.88%	67.88%	67.88%	67.88%	67.88%	67.88%	67.88%	67.88%	67.88%	67.88%	67.88%
FIIs	0.31%	0.37%	0.74%	1.15%	1.88%	1.87%	2.07%	2.35%	3.00%	3.21%	3.08%	3.76%
DIIs	0.02%	0.02%	0.02%	0.02%	0.03%	0.02%	0.02%	0.08%	0.13%	0.14%	0.18%	0.21%
Public	31.79%	31.73%	31.37%	30.95%	30.20%	30.23%	30.04%	29.69%	28.97%	28.77%	28.86%	28.15%
No. of Shareholders	36,279	35,755	43,257	43,180	40,571	40,550	48,399	47,751	51,172	52,823	58,795	60,527

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	37.95	32.94	21.31	15.90	10.71
Diluted EPS (Rs.)	37.95	32.94	21.31	15.90	10.71
Cash EPS (Rs.)	48.57	40.82	28.00	20.61	15.29
Book Value[Excl.RevalReserv]/Share (Rs.)	146.95	139.96	137.19	115.76	99.20
Book Value[Incl.RevalReserv]/Share (Rs.)	147.03	140.03	137.27	115.83	99.28
Revenue From Operations / Share (Rs.)	387.09	326.04	273.78	214.29	198.84
PBDIT / Share (Rs.)	64.33	53.10	38.72	26.17	20.60
PBIT / Share (Rs.)	53.70	45.22	32.02	21.46	16.02
PBT / Share (Rs.)	50.71	43.46	31.29	20.95	15.59
Net Profit / Share (Rs.)	37.95	32.94	21.31	15.90	10.71
NP After MI And SOA / Share (Rs.)	37.95	32.94	21.31	15.90	10.71
PBDIT Margin (%)	16.61	16.28	14.14	12.21	10.36
PBIT Margin (%)	13.87	13.86	11.69	10.01	8.05
PBT Margin (%)	13.10	13.32	11.42	9.77	7.83
Net Profit Margin (%)	9.80	10.10	7.78	7.42	5.38
NP After MI And SOA Margin (%)	9.80	10.10	7.78	7.42	5.38
Return on Networth / Equity (%)	25.82	23.53	15.53	13.73	10.79
Return on Capital Employeed (%)	28.32	26.21	19.63	16.89	14.40
Return On Assets (%)	13.38	12.50	9.95	9.35	6.87
Long Term Debt / Equity (X)	0.03	0.03	0.01	0.01	0.01
Total Debt / Equity (X)	0.21	0.29	0.02	0.01	0.12
Asset Turnover Ratio (%)	1.42	0.84	0.79	0.70	0.65
Current Ratio (X)	2.24	2.24	3.17	3.21	2.70
Quick Ratio (X)	0.86	0.70	1.20	1.37	1.20
Inventory Turnover Ratio (X)	1.59	1.31	1.39	1.21	1.23
Dividend Payout Ratio (NP) (%)	89.59	24.28	9.38	0.00	214.80
Dividend Payout Ratio (CP) (%)	69.99	19.59	7.14	0.00	150.43
Earning Retention Ratio (%)	10.41	75.72	90.62	0.00	-114.80
Cash Earning Retention Ratio (%)	30.01	80.41	92.86	0.00	-50.43
Interest Coverage Ratio (X)	21.54	30.18	52.69	51.73	47.59
Interest Coverage Ratio (Post Tax) (X)	13.70	19.72	30.00	32.44	25.73
Enterprise Value (Cr.)	4411.67	1882.76	913.42	896.66	486.31
EV / Net Operating Revenue (X)	1.59	0.80	0.46	0.58	0.34
EV / EBITDA (X)	9.59	4.96	3.30	4.79	3.30
MarketCap / Net Operating Revenue (X)	1.54	0.69	0.49	0.65	0.32
Retention Ratios (%)	10.40	75.71	90.61	0.00	-114.80
Price / BV (X)	4.05	1.61	0.99	1.21	0.65
Price / Net Operating Revenue (X)	1.54	0.69	0.49	0.65	0.32
EarningsYield	0.06	0.14	0.15	0.11	0.16

After reviewing the key financial ratios for Banco Products (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
For Diluted EPS (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
For Cash EPS (Rs.), as of Mar 24, the value is 48.57. This value is within the healthy range. It has increased from 40.82 (Mar 23) to 48.57, marking an increase of 7.75.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 146.95. It has increased from 139.96 (Mar 23) to 146.95, marking an increase of 6.99.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 147.03. It has increased from 140.03 (Mar 23) to 147.03, marking an increase of 7.00.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 387.09. It has increased from 326.04 (Mar 23) to 387.09, marking an increase of 61.05.
For PBDIT / Share (Rs.), as of Mar 24, the value is 64.33. This value is within the healthy range. It has increased from 53.10 (Mar 23) to 64.33, marking an increase of 11.23.
For PBIT / Share (Rs.), as of Mar 24, the value is 53.70. This value is within the healthy range. It has increased from 45.22 (Mar 23) to 53.70, marking an increase of 8.48.
For PBT / Share (Rs.), as of Mar 24, the value is 50.71. This value is within the healthy range. It has increased from 43.46 (Mar 23) to 50.71, marking an increase of 7.25.
For Net Profit / Share (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
For PBDIT Margin (%), as of Mar 24, the value is 16.61. This value is within the healthy range. It has increased from 16.28 (Mar 23) to 16.61, marking an increase of 0.33.
For PBIT Margin (%), as of Mar 24, the value is 13.87. This value is within the healthy range. It has increased from 13.86 (Mar 23) to 13.87, marking an increase of 0.01.
For PBT Margin (%), as of Mar 24, the value is 13.10. This value is within the healthy range. It has decreased from 13.32 (Mar 23) to 13.10, marking a decrease of 0.22.
For Net Profit Margin (%), as of Mar 24, the value is 9.80. This value is within the healthy range. It has decreased from 10.10 (Mar 23) to 9.80, marking a decrease of 0.30.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.80. This value is within the healthy range. It has decreased from 10.10 (Mar 23) to 9.80, marking a decrease of 0.30.
For Return on Networth / Equity (%), as of Mar 24, the value is 25.82. This value is within the healthy range. It has increased from 23.53 (Mar 23) to 25.82, marking an increase of 2.29.
For Return on Capital Employeed (%), as of Mar 24, the value is 28.32. This value is within the healthy range. It has increased from 26.21 (Mar 23) to 28.32, marking an increase of 2.11.
For Return On Assets (%), as of Mar 24, the value is 13.38. This value is within the healthy range. It has increased from 12.50 (Mar 23) to 13.38, marking an increase of 0.88.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.03.
For Total Debt / Equity (X), as of Mar 24, the value is 0.21. This value is within the healthy range. It has decreased from 0.29 (Mar 23) to 0.21, marking a decrease of 0.08.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.42. It has increased from 0.84 (Mar 23) to 1.42, marking an increase of 0.58.
For Current Ratio (X), as of Mar 24, the value is 2.24. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.24.
For Quick Ratio (X), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.70 (Mar 23) to 0.86, marking an increase of 0.16.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.59. This value is below the healthy minimum of 4. It has increased from 1.31 (Mar 23) to 1.59, marking an increase of 0.28.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 89.59. This value exceeds the healthy maximum of 50. It has increased from 24.28 (Mar 23) to 89.59, marking an increase of 65.31.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 69.99. This value exceeds the healthy maximum of 50. It has increased from 19.59 (Mar 23) to 69.99, marking an increase of 50.40.
For Earning Retention Ratio (%), as of Mar 24, the value is 10.41. This value is below the healthy minimum of 40. It has decreased from 75.72 (Mar 23) to 10.41, marking a decrease of 65.31.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 30.01. This value is below the healthy minimum of 40. It has decreased from 80.41 (Mar 23) to 30.01, marking a decrease of 50.40.
For Interest Coverage Ratio (X), as of Mar 24, the value is 21.54. This value is within the healthy range. It has decreased from 30.18 (Mar 23) to 21.54, marking a decrease of 8.64.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 13.70. This value is within the healthy range. It has decreased from 19.72 (Mar 23) to 13.70, marking a decrease of 6.02.
For Enterprise Value (Cr.), as of Mar 24, the value is 4,411.67. It has increased from 1,882.76 (Mar 23) to 4,411.67, marking an increase of 2,528.91.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.59. This value is within the healthy range. It has increased from 0.80 (Mar 23) to 1.59, marking an increase of 0.79.
For EV / EBITDA (X), as of Mar 24, the value is 9.59. This value is within the healthy range. It has increased from 4.96 (Mar 23) to 9.59, marking an increase of 4.63.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 0.69 (Mar 23) to 1.54, marking an increase of 0.85.
For Retention Ratios (%), as of Mar 24, the value is 10.40. This value is below the healthy minimum of 30. It has decreased from 75.71 (Mar 23) to 10.40, marking a decrease of 65.31.
For Price / BV (X), as of Mar 24, the value is 4.05. This value exceeds the healthy maximum of 3. It has increased from 1.61 (Mar 23) to 4.05, marking an increase of 2.44.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 0.69 (Mar 23) to 1.54, marking an increase of 0.85.
For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to 0.06, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Banco Products (India) Ltd as of May 23, 2025 is: 502.42

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 23, 2025, Banco Products (India) Ltd is Overvalued by 9.64% compared to the current share price 556.00

Intrinsic Value of Banco Products (India) Ltd as of May 23, 2025 is: 612.63

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 23, 2025, Banco Products (India) Ltd is Undervalued by 10.19% compared to the current share price 556.00

Last 5 Year EPS CAGR: 21.94%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 19.00%, which is a positive sign. The company has higher reserves (799.00 cr) compared to borrowings (157.85 cr), indicating strong financial stability. The company has shown consistent growth in sales (1.31 cr) and profit (190.15 cr) over the years.	The stock has a high average Working Capital Days of 124.67, which may not be favorable. The stock has a high average Cash Conversion Cycle of 187.42, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Banco Products (India) Ltd:
1. Net Profit Margin: 9.8%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 28.32% (Industry Average ROCE: 16.45%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 25.82% (Industry Average ROE: 14.45%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 13.7
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.86
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 20.3 (Industry average Stock P/E: 76.32)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.21
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Banco Products (India) Ltd. is a Public Limited Listed company incorporated on 16/03/1961 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L51100GJ1961PLC001039 and registration number is 001039. Currently Company is involved in the business activities of Manufacture of diverse parts and accessories for motor vehecles sucs as brakes, gearboxes, axles, road wheels, suspension shock absorbers, radiators, silencers, exhaust pipes, catalysers, clutches, steering wheels, steering columns and steering boxes etc.. Company's Total Operating Revenue is Rs. 1104.98 Cr. and Equity Capital is Rs. 28.61 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Auto Ancl - Engine Parts	Bil, Near Bhaili Railway Station, Vadodra District Gujarat 391410	investor@bancoindia.com http://www.bancoindia.com

Management
Name	Position Held
Mr. Mehul K Patel	Chairman
Ms. Himali Patel	WholeTime Director & CFO
Mr. Sharan M Patel	Whole Time Director
Mr. Shivam M Patel	Non Executive Director
Ms. Ameeta V Manohar	Independent Director
Mr. Ramkisan Devidayal	Independent Director
Mr. Mukesh D Patel	Independent Director
Mr. Devesh A Pathak	Independent Director
Mr. Udayan P Patel	Independent Director
Mr. Tarak A Patel	Independent Director

FAQ

What is the intrinsic value of Banco Products (India) Ltd?

Banco Products (India) Ltd's intrinsic value (as of 23 May 2025) is ₹502.42 — 9.64% lower the current market price of 556.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,942 Cr. market cap, FY2025-2026 high/low of ₹603/259, reserves of 1,259 Cr, and liabilities of 2,342 Cr.

What is the Market Cap of Banco Products (India) Ltd?

The Market Cap of Banco Products (India) Ltd is 7,942 Cr..

What is the current Stock Price of Banco Products (India) Ltd as on 23 May 2025?

The current stock price of Banco Products (India) Ltd as on 23 May 2025 is 556.

What is the High / Low of Banco Products (India) Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Banco Products (India) Ltd stocks is ₹603/259.

What is the Stock P/E of Banco Products (India) Ltd?

The Stock P/E of Banco Products (India) Ltd is 20.3.

What is the Book Value of Banco Products (India) Ltd?

The Book Value of Banco Products (India) Ltd is 91.1.

What is the Dividend Yield of Banco Products (India) Ltd?

The Dividend Yield of Banco Products (India) Ltd is 1.98 %.

What is the ROCE of Banco Products (India) Ltd?

The ROCE of Banco Products (India) Ltd is 33.4 %.

What is the ROE of Banco Products (India) Ltd?

The ROE of Banco Products (India) Ltd is 33.3 %.

What is the Face Value of Banco Products (India) Ltd?

The Face Value of Banco Products (India) Ltd is 2.00.